Effectiveness of mRNA COVID-19 vaccine boosters against infection, hospitalization and death: a target trial emulation in the omicron (B.1.1.529) variant era
View ORCID ProfileGeorge N. Ioannou, Amy SB Bohnert, Ann M. O’Hare, Edward J. Boyko, Matthew L. Maciejewski, Valerie A. Smith, C. Barrett Bowling, Elizabeth Viglianti, Theodore J. Iwashyna, Denise M. Hynes, Kristin Berry, the COVID-19 Observational Research Collaboratory (CORC)
doi: https://doi.org/10.1101/2022.06.15.22276466
George N. Ioannou
1Divisions of Gastroenterology, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, WA, USA
2Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA
BMBCh, MSAmy SB Bohnert
7Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI
14Center for Clinical Management Research, VA Ann Arbor Health System, Ann Arbor, MI, USA
PhDAnn M. O’Hare
6Nephrology, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, WA, USA
MDEdward J. Boyko
8General Internal Medicine, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, WA, USA
MD MPHMatthew L. Maciejewski
9Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, North Carolina, USA.
10Department of Population Health Sciences, Duke University School of Medicine, Durham, NC USA
11Duke-Margolis Center for Health Policy, Duke University School of Medicine, Durham, North Carolina, USA
12Division of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina, USA
PhDValerie A. Smith
9Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, North Carolina, USA.
10Department of Population Health Sciences, Duke University School of Medicine, Durham, NC USA
12Division of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina, USA
DrPHC. Barrett Bowling
13Durham Veterans Affairs Geriatric Research Education and Clinical Center, Durham Veterans Affairs Medical Center (VAMC), Durham, NC and Department of Medicine, Duke University, Durham, NC
MD, MSPHElizabeth Viglianti
14Center for Clinical Management Research, VA Ann Arbor Health System, Ann Arbor, MI, USA
15Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
MDTheodore J. Iwashyna
14Center for Clinical Management Research, VA Ann Arbor Health System, Ann Arbor, MI, USA
15Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
MD PhDDenise M. Hynes
5Center of Innovation to Improve Veteran Involvement in Care, VA Portland Healthcare System, Portland, OR
6Nephrology, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, WA, USA
MPH, PhD, RNKristin Berry
2Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA
PhDData Availability
Data produced in the present study are available only to investigators who have appropriate regulatory approval according to the regulations of the Veterans Affairs Office of Research and Development
Data Availability
Data produced in the present study are available only to investigators who have appropriate regulatory approval according to the regulations of the Veterans Affairs Office of Research and Development
Posted June 16, 2022.
Effectiveness of mRNA COVID-19 vaccine boosters against infection, hospitalization and death: a target trial emulation in the omicron (B.1.1.529) variant era
George N. Ioannou, Amy SB Bohnert, Ann M. O’Hare, Edward J. Boyko, Matthew L. Maciejewski, Valerie A. Smith, C. Barrett Bowling, Elizabeth Viglianti, Theodore J. Iwashyna, Denise M. Hynes, Kristin Berry, the COVID-19 Observational Research Collaboratory (CORC)
medRxiv 2022.06.15.22276466; doi: https://doi.org/10.1101/2022.06.15.22276466
Effectiveness of mRNA COVID-19 vaccine boosters against infection, hospitalization and death: a target trial emulation in the omicron (B.1.1.529) variant era
George N. Ioannou, Amy SB Bohnert, Ann M. O’Hare, Edward J. Boyko, Matthew L. Maciejewski, Valerie A. Smith, C. Barrett Bowling, Elizabeth Viglianti, Theodore J. Iwashyna, Denise M. Hynes, Kristin Berry, the COVID-19 Observational Research Collaboratory (CORC)
medRxiv 2022.06.15.22276466; doi: https://doi.org/10.1101/2022.06.15.22276466
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12562)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)